File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Individualized treatment in stage IVC nasopharyngeal carcinoma

TitleIndividualized treatment in stage IVC nasopharyngeal carcinoma
Authors
Chan, Oscar S HNgan, Roger K C
Issue Date2014
Citation
Oral Oncology, 2014, v. 50, n. 9, p. 791-797 How to Cite?
DOI: http://dx.doi.org/10.1016/j.oraloncology.2014.01.004
AbstractThe stage IVC nasopharyngeal carcinoma is a catch-all entity covering minute solitary metastasis to bulky disseminated disease. Prognosis varies greatly within this stage group. A subset of patients with oligometastases may benefit from aggressive local ablative therapy. Meanwhile, in multiple metastatic diseases, customizing conventional cytotoxics basing on individual tumor characteristics and previous chemotherapy responses can be a new direction to improve therapeutic results. Prognostic models built on clinical features and genomic profiles can be utilized to stratify different risk groups and tailor therapy schemes. © 2014 Elsevier Ltd. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/251668
ISSN
1368-8375
2023 Impact Factor: 4.0
2023 SCImago Journal Rankings: 1.257
ISI Accession Number ID
WOS:000340267300005

 

DC FieldValueLanguage
dc.contributor.authorChan, Oscar S H-
dc.contributor.authorNgan, Roger K C-
dc.date.accessioned2018-03-08T05:00:38Z-
dc.date.available2018-03-08T05:00:38Z-
dc.date.issued2014-
dc.identifier.citationOral Oncology, 2014, v. 50, n. 9, p. 791-797-
dc.identifier.issn1368-8375-
dc.identifier.urihttp://hdl.handle.net/10722/251668-
dc.description.abstractThe stage IVC nasopharyngeal carcinoma is a catch-all entity covering minute solitary metastasis to bulky disseminated disease. Prognosis varies greatly within this stage group. A subset of patients with oligometastases may benefit from aggressive local ablative therapy. Meanwhile, in multiple metastatic diseases, customizing conventional cytotoxics basing on individual tumor characteristics and previous chemotherapy responses can be a new direction to improve therapeutic results. Prognostic models built on clinical features and genomic profiles can be utilized to stratify different risk groups and tailor therapy schemes. © 2014 Elsevier Ltd. All rights reserved.-
dc.languageeng-
dc.relation.ispartofOral Oncology-
dc.titleIndividualized treatment in stage IVC nasopharyngeal carcinoma-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.oraloncology.2014.01.004-
dc.identifier.pmid24518920-
dc.identifier.scopuseid_2-s2.0-84905906170-
dc.identifier.volume50-
dc.identifier.issue9-
dc.identifier.spage791-
dc.identifier.epage797-
dc.identifier.eissn1879-0593-
dc.identifier.isiWOS:000340267300005-
dc.identifier.issnl1368-8375-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats